Literature DB >> 23349013

Genetic susceptibility to lung cancer--light at the end of the tunnel?

Ariela L Marshall1, David C Christiani.   

Abstract

Lung cancer is one of the most common and deadliest cancers in the world. The major socio-environmental risk factor involved in the development of lung cancer is cigarette smoking. Additionally, there are multiple genetic factors, which may also play a role in lung cancer risk. Early work focused on the presence of relatively prevalent but low-penetrance alterations in candidate genes leading to increased risk of lung cancer. Development of new technologies such as genomic profiling and genome-wide association studies has been helpful in the detection of new genetic variants likely involved in lung cancer risk. In this review, we discuss the role of multiple genetic variants and review their putative role in the risk of lung cancer. Identifying genetic biomarkers and patterns of genetic risk may be useful in the earlier detection and treatment of lung cancer patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23349013      PMCID: PMC3581605          DOI: 10.1093/carcin/bgt016

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  298 in total

1.  Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.

Authors:  B Zhang; A Henney; P Eriksson; A Hamsten; H Watkins; S Ye
Journal:  Hum Genet       Date:  1999-11       Impact factor: 4.132

2.  Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Authors:  Daphne W Bell; Ira Gore; Ross A Okimoto; Nadia Godin-Heymann; Raffaella Sordella; Roseann Mulloy; Sreenath V Sharma; Brian W Brannigan; Gayatry Mohapatra; Jeff Settleman; Daniel A Haber
Journal:  Nat Genet       Date:  2005-10-30       Impact factor: 38.330

3.  The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis.

Authors:  Jin Huang; Jie Zhang; Yuliang Zhao; Banghua Liao; Jiaming Liu; Ling Li; Mingheng Liao; Lanlan Wang
Journal:  Mol Biol Rep       Date:  2011-04-16       Impact factor: 2.316

4.  International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Authors:  Therese Truong; Wiebke Sauter; James D McKay; H Dean Hosgood; Carla Gallagher; Christopher I Amos; Margaret Spitz; Joshua Muscat; Philip Lazarus; Thomas Illig; H Erich Wichmann; Heike Bickeböller; Angela Risch; Hendrik Dienemann; Zuo-Feng Zhang; Behnaz Pezeshki Naeim; Ping Yang; Shanbeh Zienolddiny; Aage Haugen; Loïc Le Marchand; Yun-Chul Hong; Jin Hee Kim; Eric J Duell; Angeline S Andrew; Chikako Kiyohara; Hongbing Shen; Keitaro Matsuo; Takeshi Suzuki; Adeline Seow; Daniel P K Ng; Qing Lan; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Vali Constantinescu; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Neil E Caporaso; Demetrius Albanes; Michael Thun; Maria Teresa Landi; Joanna Trubicka; Marcin Lener; Jan Lubinski; Ying Wang; Amélie Chabrier; Paolo Boffetta; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2010-01-27       Impact factor: 4.944

5.  Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.

Authors:  Yifeng Zhou; Chunyuan Yu; Xiaoping Miao; Yonggang Wang; Wen Tan; Tong Sun; Xuemei Zhang; Ping Xiong; Dongxin Lin
Journal:  Carcinogenesis       Date:  2005-02-24       Impact factor: 4.944

6.  The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population.

Authors:  Jiaoyang Yin; Ulla Vogel; Yegang Ma; Rong Qi; Zhongfu Sun; Huiwen Wang
Journal:  Lung Cancer       Date:  2007-02-20       Impact factor: 5.705

Review 7.  Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis.

Authors:  C Carlsten; G S Sagoo; A J Frodsham; W Burke; J P T Higgins
Journal:  Am J Epidemiol       Date:  2008-02-12       Impact factor: 4.897

8.  Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer.

Authors:  Daniele Campa; Shanbeh Zienolddiny; Valentina Maggini; Vidar Skaug; Aage Haugen; Federico Canzian
Journal:  Carcinogenesis       Date:  2003-11-06       Impact factor: 4.944

9.  Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies.

Authors:  Zheng Ye; Honglin Song; Julian P T Higgins; Paul Pharoah; John Danesh
Journal:  PLoS Med       Date:  2006-03-07       Impact factor: 11.069

10.  A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

Authors:  Yan Lu; William Lemon; Peng-Yuan Liu; Yijun Yi; Carl Morrison; Ping Yang; Zhifu Sun; Janos Szoke; William L Gerald; Mark Watson; Ramaswamy Govindan; Ming You
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

View more
  32 in total

1.  Examining Gender Differences in Lung Cancer Screening.

Authors:  Simran Randhawa; Shelby R Sferra; Chandra Das; Larry R Kaiser; Grace X Ma; Cherie P Erkmen
Journal:  J Community Health       Date:  2020-10

Review 2.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

3.  CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis.

Authors:  Zheng Ma; Wei Guo; Taiqian Gong; Hui-Jun Niu; Ru-Wen Wang; Yao-Guang Jiang
Journal:  Tumour Biol       Date:  2013-11-29

4.  Drugs for preventing lung cancer in healthy people.

Authors:  Marcela Cortés-Jofré; José-Ramón Rueda; Claudia Asenjo-Lobos; Eva Madrid; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

Review 5.  Lung cancer mutations and use of targeted agents in Hispanics.

Authors:  W Douglas Cress; Alberto Chiappori; Pedro Santiago; Teresita Muñoz-Antonia
Journal:  Rev Recent Clin Trials       Date:  2014

6.  Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population.

Authors:  Juncheng Dai; Wei Shen; Wanqing Wen; Jiang Chang; Tongmin Wang; Haitao Chen; Guangfu Jin; Hongxia Ma; Chen Wu; Lian Li; Fengju Song; YiXin Zeng; Yue Jiang; Jiaping Chen; Cheng Wang; Meng Zhu; Wen Zhou; Jiangbo Du; Yongbing Xiang; Xiao-Ou Shu; Zhibin Hu; Weiping Zhou; Kexin Chen; Jianfeng Xu; Weihua Jia; Dongxin Lin; Wei Zheng; Hongbing Shen
Journal:  Int J Cancer       Date:  2016-10-11       Impact factor: 7.396

Review 7.  Women and lung cancer: what is new?

Authors:  Crystal M North; David C Christiani
Journal:  Semin Thorac Cardiovasc Surg       Date:  2013

8.  MicroRNA-299-3p promotes the sensibility of lung cancer to doxorubicin through directly targeting ABCE1.

Authors:  Dawei Zheng; Yan Dai; Song Wang; Xiaoyu Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Association between CBR1 polymorphisms and NSCLC in the Chinese population.

Authors:  Yong Guo; Yingying Shen; Yongming Xia; Jianzhong Gu
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

Review 10.  Genetic susceptibility to lung cancer and co-morbidities.

Authors:  Ian A Yang; John W Holloway; Kwun M Fong
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.